Rituxan in the treatment of cold agglutinin disease

Blood. 1998 Nov 1;92(9):3490-1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Anemia, Hemolytic, Autoimmune / etiology
  • Anemia, Hemolytic, Autoimmune / therapy*
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents, Alkylating / therapeutic use
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Combined Modality Therapy
  • Cyclophosphamide / therapeutic use
  • Female
  • Humans
  • Immunization, Passive*
  • Lymphoma, B-Cell / complications
  • Lymphoma, B-Cell / therapy*
  • Prednisone / therapeutic use
  • Rituximab

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents, Alkylating
  • Antineoplastic Agents, Hormonal
  • Rituximab
  • Cyclophosphamide
  • Prednisone